CRISPR Humans: Ethics at the Edge of Science by Hyun, Insoo
Western Michigan University
ScholarWorks at WMU
Center for the Study of Ethics in Society Papers Center for the Study of Ethics in Society
8-2016
CRISPR Humans: Ethics at the Edge of Science
Insoo Hyun
Case Western Reserve University, insoo.hyun@case.edu
Follow this and additional works at: http://scholarworks.wmich.edu/ethics_papers
Part of the Bioethics and Medical Ethics Commons, Business Law, Public Responsibility, and
Ethics Commons, Ethics and Political Philosophy Commons, Ethics in Religion Commons, and the
Legal Ethics and Professional Responsibility Commons
This Complete Issue is brought to you for free and open access by the
Center for the Study of Ethics in Society at ScholarWorks at WMU. It has
been accepted for inclusion in Center for the Study of Ethics in Society
Papers by an authorized administrator of ScholarWorks at WMU. For more
information, please contact maira.bundza@wmich.edu.
WMU ScholarWorks Citation
Hyun, Insoo, "CRISPR Humans: Ethics at the Edge of Science" (2016). Center for the Study of Ethics in Society Papers. 108.
http://scholarworks.wmich.edu/ethics_papers/108
Center for the 
Study of 
Ethics in 
Society 
Papers published by the Center 
Vol. XXII No.3 
August, 2016 
~ I Insoo Hyun, Ph.D. · . 
1 Associate ~rofessor or'Bioethics ana Philosophy, 
"" • l •I _ Department of Btoethics ' 
Case Western Reserve University 
·'"( . 
School of ~edici!!e ~~ 
. ·-...t'/S. (!t'.,,., ,...._.......,.;~- ~ ~ 
Center for the Study of Ethics in Society 
Founded 1985 
Western Michigan University 
2073 Moore Hall 
1903 West Michigan Avenue 
Kalamazoo, MI 49008-5328 
The purpose of WMU's Center for the Study of Ethics is to encourage and support 
research, teaching, and service to the university and community in areas of 
applied and professional ethics. These areas include, but are not restricted to: 
business, education, engineering, government, health and human services, law, 
media, medicine, science and technology. 
Tel: 269-387-4397 
Fax: 269-387-4390 
Advisory Board 
Sandra L. Borden, Director 
Communication, 387-0362 
Michael S. Pritchard, Founding 
Director, Philosophy 
Shirley Bach, Associate Director 
Philosophy 
Jil Larson, Publications Editor 
English, 387-2587 
Fritz Allhoff 
Philosophy 
Raja G. Aravamuthan 
Paper Engineering, Chemical 
Engineering, and Imaging 
Paul Farber 
Teaching, Learning and Educational 
Studies 
Norman W. Hawker 
Financial & Commercial Law 
ethicscenter@wmich.edu 
http: //www. wmich.edu/ethics 
Ronald Kramer 
Sociology 
Mary Lagerway 
Bronson School ofNursing 
Paul Pancella 
Physics 
Linda Reeser 
Social Work 
William Santiago-Valles 
Africana Studies 
Susan Stapleton 
Chemistry 
Victoria Vuletich, 
WMU Cooley Law School 
CRISPR Humans: 
Ethics at the Edge of Science 
Presented March 17,2016 
Insoo Hyun, Ph.D. 
Papers presented fo r th e 
Center fo r the Stud y of Ethi cs in Society 
Western Michi gan Uni versity 
Vo l. XX II No. 3 
August, 20 16 
Dr. Insoo Hyun 
Dr. Insoo Hyun is Associate Professor of Bioethics and Philosophy 
at Case Western Reserve University School of Medicine in 
Cleveland, Ohio. Prior to coming to CWRU, Dr. Hyun taught in the 
Philosophy Department at Western Michigan University. His 
research interests include ethical and policy issues in stem cell 
research, research ethics and informed consent, and medical 
decision-making. 
In 2005, he was awarded a Fulbright Research Award by the 
U.S. Depat1ment of State to study the ethical, legal , and cultural 
dynamics of human research cloning in South Korea. In 2006 he 
chaired the Subcommittee on Human Biological Materials 
Procurement for the International Embryonic Stem Cel l Guide lines 
Task Force, a multinational, multidisciplinary working group for the 
ISSCR (International Society for Stem Cell Research). [n 2007 he 
served as Co-Chairperson ofthe ISSCR Task Force on International 
Guidelines for the Clinical Translation of Stem Cells. He is also the 
past Chairperson ofthe JSSCR's Ethics and Public Policy 
Committee. Currently, Dr. Hyun is a member of the ISSCR 
Working Group that revised the lSSCR guidelines for basic and 
translational stem cell research. 
Dr. Hyun received his B.A. and M.A. in philosophy from 
Stanford University and his Ph .D. in philosophy from Brown 
University. Dr. Hyun ' s bioethics at1icles have appeared in Science, 
Nature, Cell Stem Cell, The Hastings Center Report, and The 
Kennedy Institute of Ethics Journal , among many others. His book 
Bioethics and the Future of Stem Cell Research was published by 
Cambridge University Press. 
Dr. Hyun presented this talk as a keynote address at the 
Bioethics: Preparing for the Unknown conference held to observe 
the Ethics Center' s 301h anniversary. 
insoo.hyun@case.edu 
The Center for the Study of Ethi cs in Society, Vol. XXII No. 3 
CRISPR Humans: Ethics at the Edge of Science 
Insoo Hyun, Ph.D. 
Associate Professor ofBioethics and Philosophy 
Depat1ment of B ioethics 
Case Western Reserve University 
School ofMedicine 
I 
Advances in human gene editing have raised considerable at-
tention among researchers, regulators, and the public in recent 
months. In this paper, I begin by offering a brief account of both the 
"tools of the trade" and the main applications of human gene editing. 
Then I describe recent efforts toward the formation of international 
guidelines. I conclude with some reflections on ethics at the edge of 
science. 
Genetic engineering has come a long way in the past 40 plus 
years. The latest laboratory tools- zinc finger nuclease, TALEN, and 
CRISPR Cas9 - allow researchers to make precise deletions and sub-
stitutions along the genomes of any species. Among these tools , 
CRISPR Cas9 has garnered the most attention in recent months be-
cause it offers by far the fastest and easiest means to edit genes. 1 An-
yone can learn to use it in one day. 
The CRISPR system is a naturally occurring acquired immune 
system found in bacteria and archaea. It allows single-cel l organisms 
1 In the past few months, hundreds of news articles have appeared aro~md the world 
in the popular and scientific press about the CRISPR revolution, including this Ne w 
York Times i\1/agazine piece, "The CRlSPR Quandary," NYT Magazine, November 
9, 2015: http ://www.nytimes.com/20l5/ llll5/magazine/the-crispr-
q uandary .htm I? _ r=O. 
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to cut and deactivate foreign genetic elements introduced by invading 
viruses and plasm ids. Researchers discovered a couple of years ago 
that a specific nuclease (enzyme) in the CRJSPR system, Cas9, could 
be used to add, silence, or alter DNA at any location by using the 
proper guide RNAs to target the desired sequence. CRISPR Cas9 is 
so precise that it can even be used to edit a single base pair within a 
gene . Now other CRISPR nucleases are being discovered that could 
broaden the genetic engineering toolkit even further. 2 
Lately scientists have been using CRISPR Cas9 and other 
gene editing technologies experimentally to modify the somatic 
(body) cell DNA of individuals suffering from serious genetic diseas-
es. Most recently, an infant suffering from a rare and aggressive form 
of leukemia was treated in London using "off the shelf' T cells that 
were genetically modified using TALEN to enable them to hide from 
her own immune system. By all accounts, she is doing very well. 3 In 
another study reported in Science, researchers were able to use 
CRISPR to heal mice affected with Duchenne muscular dystrophy 
(DMD), allowing the animals to make an essential muscle protein 
called dystrophin in their muscle stem cells. 4 Without dystrophin to 
strengthen and protect muscle fibers, people with DMD die by around 
age 25 . With more precise gene editing tools at their di sposal, sc ien-
tists are starting to believe that the full promise of somatic cell "gene 
therapies" might finally be within reach. In recognition of these rapid 
and important advances, Science has hailed CRlSPR as the 2015 
Breakthrough ofthe Year. 5 
2 See Jacob, Julie A. (20 15). "Four New CRISPR Nucleases Characterized," JAMA 
3 14 (24): 2607. 
3 "Gene Ed iting Saves Gir l Dying From Leukaemia in World First," The Ne111 Scien-
tist , November 5, 2015 . 
4 Tabebordbar, M., eta/. (20 15). " In Vivo Gene Ed iting in Dystrophic Mouse Mus-
cle and Muscle Stem Cell s," Science DOl: I 0. 1126/science.aad5177. 
5 McNutt, Marcia. (20 15). " Breakthrough to Genome Editing," Science 350 (6267): 
1445. 
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Despite the growing excitement over CRISPR applications for 
patients, deep-seated ethical and social concerns loom on the horizon. 
The first (often overlooked) critical aspect of gene editing involves 
the unknown dangers of attempting to use CRISPR nucleases to edit 
the genes of living people for their health benefit. As early experi-
ence with gene transfer research nearly two decades ago suggests, the 
use of genetic engineering interventions during the course of a clini-
cal trial can come with unexpected adverse events, such as was the 
case with Jesse Gelsinger, a 19 year-old patient who volunteered for 
an early phase safety study of a gene therapy protocol at the Universi-
ty of Pennsylvania. A few days after he entered the study, Gelsinger 
died suddenly due to an unanticipated immune reaction to a gene 
therapy vector introduced into his liver by investigators. This cata-
strophic outcome effectively shut down clinical trials of gene transfer 
research for many years as the FDA and federal regulators tried to 
assess the causes of this event and the steps necessary to minimize the 
likelihood of such an occurrence in the future. Another Gelsinger-
like adverse event, this time for CRISPR-mediated interventions for 
genetic disease, could stall the promise of gene editing for patients for 
years if investigators are too cavalier about possible risks. Just be-
cause we have already been down the road of somatic cell gene inter-
ventions for patients does not mean that this is a road free of potential 
pitfalls. 
A second, much more scrutinized area of human gene editing 
lies its potential effect on future generations. In addition to designing 
somatic cell therapies, some researchers have also become interested 
in discovering whether CRISPR Cas9 and other nucleases can be used 
to alter the human germ line, i.e. , the lineage of cells from which hu-
man germ cells (sperm and eggs) are derived. In theory, the human 
germ line could be modified by altering the genes of sperm , eggs, or 
zygotes. Unlike somatic cell modifications, any changes to the germ 
line would be passed to subsequent generations. Where do the ethical 
3 
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limitations ofthis new technology lie? Some worry that scientists 
may be going too far too quickly. The purpose of human germ line 
editing would be (at least initially) to replace known harmful genes, 
such as the gene responsible for cystic fibrosis , so that parents who 
are carriers can avoid transmitting genetic harms to their offspring 
while remaining otherwise genetica lly connected to their children. 
For individuals with a family history of a serious genetic disease, one 
perceived benefit of human germ line modification would be tore-
move the threat of the disease for all their descendants. Although so-
ciety has pondered for decades the possibility of one day creating 
"designer babies," first to overcome genetic diseases, then later to in-
clude soc ially-desirable genetic traits, recent advances in gene editing 
technology have rapidly moved these discussions from the realm of 
science fiction toward science reality. 
So far, CRISPR-mediated germline editing has been shown to 
work in a number of different animal species, including non-human 
primates. Transgenic animal models for research can now be gener-
ated in just one gestation cycle, as opposed to one year or more using 
the previous method of cross-breeding stem cell-derived chimeric an-
imals. Before human germline editing can become a reality, however, 
extensive preclinical research in vitro will have to be performed using 
human reproductive materials. Currently, most researchers believe 
gene editing would have to be applied to a germ cell or a single cell 
embryo in vitro in order to avoid genetic mosaicism arising from try-
ing to use CRTSPR Cas9 on multiple cells at once. For this reason , 
the use of surplus fertility clinic embryos (which are stored after the 
zygote stage) is not likely to provide a resource for preclinical human 
germline editing research . Instead, scientists will have to create their 
own embryos for research using donated human germ cells, a form of 
research that cannot be federally funded in the U.S. and many other 
countries at thi s time. 
4 
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Despite legal restrictions in the U.S. and some other countries 
that ·hinder the ease of preclinical human germ line gene editing re-
search, let alone permit the transfer of genetically-altered embryos 
into a womb to produce a pregnancy, some researchers in more per-
missive jurisdictions, such as China, have repot1ed research using 
CRISPR Cas9 to modify human embryos in vitro. Recognizing the 
need for international consensus on using CRISPR Cas9 technology 
to modify the human genome, particularly with respect to germ line 
modifications, an international summit was called in Washington DC 
in December 2015 (of which I was a participant). In the meantime, 
while scientists and bioethicists are barely beginning their efforts to 
draft international guidelines on human gene editing, research teams 
in permissive jurisdictions continue their research on modifying the 
human germ line and continue to submit their research papers to lead-
ing scientific journals (for which I was twice a reviewer). 
The advent of CRISPR technology raises two central ques-
tions: (I) the scientific question of what can be achieved using this 
technology; and (2) the ethical question of how far human gene edit-
ing ought to be pursued. The efficien<;ies and precision of CRISPR 
technology are improving every day, 6 so these two questions urgently 
need to be addressed. At the International Summit on Human Gene 
Editing last December, scientists, ethicists, and policy makers agreed 
that an ongoing discussion was necessary concerning the many ethical 
issues raised by CRISPR technology. The discussants also agreed 
that the scientific and ethical questions should be pursued simultane-
ously. 
I agree with this conclusion. However, during the course of 
the summit, it became apparent that the discussants seemed far more 
comfortable talking to one another about the science ofCRISPR and 
less at ease delving into the complex ethical issues. Often the discus-
6 Kleinstiver, B., eta/. (20 16). " High-Fidelity CRJSPR-Cas9 N ucleases With No 
Detectable Genome- Wide Off-Target Effects," Nature DOl: l 0.1038/nature 16526. 
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sants conflated ethical concerns with ("mere") regulatory FDA-level 
requirements regarding safety (an important but not ethically-
exhaustive set ofworries). A sustained exploration of the ethical is-
sues surrounding all aspects of human gene editing research is neces-
sary. 
We are already at the point where we need to take seriously 
the ethics ofthis emerging area of science. The first publication on 
human embryo (germline) editing was presented by a group of Chi-
nese scientists in 2015. 7 This form of research immediately raises 
four important questions concerning human embryo editing: (1) what 
are the technical challenges and how do these challenges impact the 
ethics of attempting to use embryo editing in an assisted reproduction 
context; (2) what are the clinical and non-clinical (basic science) ap-
plications of human embryo editing research ; (3) what are the ethical 
issues surrounding the procurement of human gametes and embryos 
for gene editing research; and ( 4) what are the prospects of pursuing 
non-reproductive embryo editing without opening the door to repro-
ductive use? 
Embryo editing for reproductive purposes is banned in several 
countries. Nevet1heless, scientists want to pursue embryo editing re-
search to answer certain questions in developmental biology. These 
inquiries include understanding how genes direct early embryonic 
development (by using CR!SPR nucleases to turn on and off certain 
genes), understanding how non-embryonic cells are formed , and 
learning how human germ cells differentiate. Do the scholarly bene-
fits of such intellectual pursuits justify the creation and destruction of 
human embryos for research? 
This question is complicated by the fact that laws and ethical 
expectations differ around the world when it comes to human gene 
editing. Some countries, such as the U.S. and the U.K. , have very 
7 Liang, P ., et al. , (20 15). "CR.I SPR/Cas9-Mediated Gene Ed iting in Human Tripro-
nuclear Zygotes," Protein and Ce/16 (5): 363-3 72. 
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strict regulatory standards about the creation of embryos for research 
and for the introduction of genetically manipulated cells into patients, 
while other countries operate with more lax rules. Furthermore, sci-
entific journal publishing standards for this controversial area of re-
search are still evolving. As the editors of a top-tier scientific journal 
recently told me, in the absence of uniform international standards, it 
is not clear what editors should do when they receive manuscripts that 
describe research which conforms to the authors ' local ethical and 
regulatory standards but which falls far short of research ethics stand-
ards in the West. CRISPR ethical standards are needed not only for 
scientific collaboration internationally, but also for the publication of 
research results in top scientific journals. 
In the meantime, the recently updated professional and ethical 
guidelines ofthe International Society for Stem Cell Research 
(ISSCR) can help fill the void in research standards for CRISPR-
based genome editing. 8 As mentioned above, germ line editing re-
search in vitro will require the procurement of human gametes, the 
creation of embryos for research, and the oversight for embryo re-
search for basic scientific studies at the bench side. The revised 
lSSCR guidelines provide guidance for all of these areas, and in that 
way the guidelines will provide needed standards for this type of 
rsearch internationally, as other scientific societies proceed to draft 
more CRISPR-specific professional research standards. 
As I reflect on many of the issues raised by the application of 
CRISPR technology to the human genome, I cannot help but have a 
feeling of inevitability about the prospect of human germ line modifi-
cations. The edge of science only cuts forward; it never moves back. 
Already we have taken a baby step toward germ line modification for 
reproduction: mitochondrial replacement therapies, which would re-
sult in heritable changes to future generations, were approved by the 
8 Kimmelman, J. , et al. , (20 16). "Scientists Set Global Standards for Stem Cell Re-
search." Nature 533: 311-313. 
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UK Parliament last year, with the U.S. Institute of Medicine follow-
ing suit in an FDA advisory report echoing similar recommendations 
for clinical trials research . If mitochondrial replacement therapies are 
approved, then one wonders whether these interventions are really all 
that conceptually different from germline modifications that would 
occur within the nuclear genome. Why should the "geography" of 
where the alteration happens in the germ cell matter ethically? 
Just as the edge of science always cuts forward , one also may 
beg in to wonder whether scientists self-imposed " lines in the sand" 
cannot also be redrawn, on occasion, to facilitate where the next cut 
in scientific advancement can be achieved. One very timely example 
of this is the current debate over the so-called " 14-day rule" for hu-
man embryo research. 9 
Human embryo research is permitted, in many jurisdictions, as 
long as embryos are maintained in culture for less than 14 consecutive 
days of development, and experimentation is concluded before the 
appearance of the primiti ve streak (a faint band of cells markin g the 
beginning ofthe embryo ' s head-to-tail axis). This 14-day limit is en-
coded in many countries' laws governing assisted reproduction and 
embryo research. ft is also embod ied in numerous nationa l commis-
s ion recommendations and sc ientific guide lines for embryo and as-
sisted reproduction research spannin g nearl y four decades . 
As a public po licy instrument, the 14-day rule has been a tre-
mendous success. lt has offered - at least until now - a clear and le-
gall y enforceab le boundary for sc ient ific activity. One can count the 
number of days an embryo is cu ltured in a dish. The primitive streak 
is somethin g one can actua ll y see. Additiona ll y, the 14-day rule has 
the pract ica l virtue of providing a publicly-negotiated approach to 
managing human embryo research, one that is accommodating of 
many differing views on th e moral status of early embryos . The two 
oute rmost a lternatives to the 14-day rule - of favoring either a zygote 
8 
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protection position that would disallow embryo research a ltogether or 
a lai ssez-faire stance that would impose zero restrictions on embryo 
use - would not have made for good public policy in a pluralistic so-
ciety. 
Under the aegis of the 14-day rule, human embryo research 
has flourished. One ofthe most important advances to emerge from 
this protected space is human embryonic stem cell research , which 
derives cells from 5-day old pre-streak embryos in vitro. Now, 
through an ironic twist of fate, a new line of stem cell research - self-
organizing embryo-like structures and intact embryo culture- might 
begin to challenge the 14-day rule that helped enable its invention. 
Some may be unsettled by the prospect of revising this re-
search limit. But the 14-day rule is not unique in this regard. There 
are numerous examples of similarly declared limitations averred to 
protect the advancement of anxiety-provoking science: yes to human-
animal chimera research- but not at the embryo stage; yes to human 
cloning for in vitro research - but not for reproduction ; yes to pay-
ments for research egg donors ' direct expenses - but not for their 
non-financial burdens. Limitations su<;:h as these can be difficult to 
maintain in the face of evolving science. 
Since it seems to be only a matter of time before human em-
bryo modifications for reproduction become a reality, it is important 
to acknowledge that there will always be a role for ethics and philo-
sophical reflection at the edge of science. The prospect of CRISPR 
humans raises profound philosophical and ethical questions that tradi-
tionally our secular ethical approaches are not very well suited to ad-
dress. The two main approaches in bioethics today are consequential-
ist and rights-based moral frameworks. These frameworks, however, 
may not be very useful for thinking about the ethics of human 
germline modification . Unlike a harm-based or rights-based ethical 
approach, which presupposes the existence of either a being that 
9 Hyun, L, et al., (20 16). " Rev isit the 14-Day Rule." Nature 533: 169-171. 
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could be harmed by an intervention or a rights-bearer that is wronged, 
germline modifications would create a human being who would oth-
erwise not have existed but for the genetic intervention. There is no 
being or rights-bearer prior to the intervention, and thus it is not co-
herent to say that an individual is wronged as a result of gene editing; 
his or her only other alternative is non-existence. If embryo editing is 
deemed to be morally wrong, then is it because it is wrongfor some-
one (i.e. because it violates a person-affecting moral principle) or is it 
wrong because of some other, non-person-affecting reason. If the lat-
ter, then what would be the relevant non-person-affecting moral prin-
ciple? This conundrum is what Derek Parfit calls the Non-Identity 
Problem, which involves the ethics of bringing certain types of people 
into existence rather than other types of people, or what Parfit calls 
"different people choices." 10 · 
Any non-person affecting moral principle up to the task of jus-
tifying (or condemning) human germline editing would have to draw 
on values that relate to what types of people should be brought into 
existence and lay bare what we think these desirable qualities are. I 
conclude my thoughts on CRISPR and its potential use in hum ans by 
calling the reader' s attention to the metaphor of gene editing. This 
apt metaphor suggests that gene editing is an intentional activity by 
which the gene editor seeks to delete errors and insert improvements 
within the biological text ofthe human genome. Gene editing, like 
literary ed iting, presupposes that the editor must employ a set of 
background values that guide her editing decisions . Choices have to 
be ranked on a scale from better to worse, and there must be a rational 
way to select the best changes. As my brief discussion suggests, hu-
man gene editing is a new technological power that calls into action 
our deepest moral commitments and values. 
10 Parfit, Derek. ( 1986). Reasons and Persons. (Oxford : Oxford University Press). 
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IfDeliberative Democracy is the Solution, What is the 
Problem? 
No. 2, November 1999 
Emily Hauptmann 
Western Michigan University 
How Children and Adolescents Relate to Nature 
No. 3, May 2000 
Patricia Nevers 
Univers ity of Hamb urg, Germ any 
VOLUME XIII 
Ethics in Academia, 2000 
No. 1, December 2000 
Essays By Elson Floyd, Diether Haenicke, Elise Jorgens, 
With Preface By Michael Pritchard 
Western M ichigan University 
Morality and God 
No.2, February 2001 
John Hare 
Calvi n Co ll ege 
The Ethics of Making the Body Beautiful: Lessons from 
Cosmetic Surgery for A Future Of Cosmetic Genetics 
No. 3, March 2001 
Sara Goering 
California State Uni versity 
Long Beach 
VOLUME XIV 
When Hope Unblooms: Chance and Moral Luck in the 
Fiction of Thomas Hardy 
No. 1, December 200 I 
Jil Larson 
Western Michigan University 
Academic Freedom in Times of Turmoil 
No. 2, January 2002 
Petr Kolar 
Charles Universi ty 
Prague, the Czech Republic 
Teaching Research Ethics: An institutional Change 
Model 
No.3, April2002 
Michael S. Pritchard 
Western Michigan University 
Director, Center for the Study of Ethics in Society 
Brian Schrag 
Executive Secretary 
Association For Practical and Professional Ethics 
Indiana University 
Toward an Ethical School 
No.4, April2002 
Stephan Millett 
Wesley College 
Perth, Western Australia 
VOLUME XV 
The Ethics of Apology and the Role of an Ombuds from 
the Perspective of a Lawyer 
No. 1, May 2003 
Sharan Lee Levine and Paula A. Aylward 
Levine & Levine 
Kalamazoo, Michigan 
Political Correctness Today 
No.2, November 2003 
Joseph Ellin 
Western Michigan University 
Ethics and the 2JS1 Century 
No. 3, February 2004 
Judith Bailey 
Western Michigan University 
VOLUME XVI 
School Desegregation 50 Years After Brown: 
Misconceptions, Lessons Learned, and Hopes for the 
Future 
No. I, October 2005 
Gary Orfield 
Harvard University 
Universities and Corporations: A Selection of Papers 
Presented at the Western Michigan University Emeriti 
Council Forum 
No. 2, April 2006 
Media Ethics: The Powerful and the Powerless 
No.3 , April 2006 
Elaine E. Englehardt 
Utah Valley State Co ll ege 
Darwinism and the Meaning of Life 
No. 4, May 2007 
Arthur Falk 
Western M ichi gan Univers ity 
VOLUME XVII 
Professions: "Of All Professions Begging is the Best" 
A Paper by Michael Davis 
Response by Joseph Ellin 
Professor Davis' Reply 
No. I, August 2008 
Michael Davis 
Illinois In stitute of Techno logy 
Joseph Ellin 
Western Michigan University 
The Moral Justification for Journalism 
No. 2, December 2008 
Sandra Borden 
Western Michigan Uni versity 
A Free and Undemocratic Press? 
No.3, November 2009 
Stephen J .A. Ward 
Uni versity of Wisconsin-Madi son 
VOLUME XVIII 
Diversity, Democracy and Dialogue in a Human Rights 
Framework 
No.1 , June 2010 
Carol C. Gould 
City Uni versity ofNew York 
Center for the Study of Ethics in Society: 
Celebrating 25 Years 
No . 2, June 20 II 
Michael S. Pritchard, Shirley Bach, James A. Jaksa, 
Ronald Kramer 
Western Michi gan Uni vers ity 
VOLUME XIX 
Communication and the Pragmatic Condition 
No. 1, October 20 I I 
Gregory J . Shepherd 
University of Miami 
Knowledge, Wisdom, and Service: Th e Meaning and 
Teaching of Professionalism in Medicine 
No. 2, March 20 12 
Matthew K. Wynia 
The Institute fo r Ethics and the Center for Pati ent Safety, American 
Medical Assoc iation 
VOLUME XX 
Journey of Peace Journalist 
No. I, March 201 3 
Robert Koehler 
Chi cago-based synd icated journalist 
VOLUME XXI 
Anorexia/Bulimia, Transcendence, and the Potential 
Impact of Romanticized/Sexualized Death Imagery 
No. I, November2014 
Heather D. Schild 
Department of Sociology 
VOLUME XXII 
Vulnerability, Preventability, and Responsibility: 
Exploring Some Normative Implications of the Human 
Condition 
No. I, September 2015 
Daniel Wueste 
Rutland Insti tute for Ethics, C lemson Un ivers ity 
The Germans and Their Nazi Past: 
To What Extent Have They Accepted Responsibility ? 
No.2, April 2016 
Martin Hille 
University of Passau (Germany) 
Spring 2016 Lecture Series 
"Peace During War: The Ethics of Forgiveness" 
4:00p.m. Wednesday, January 27th 
3508 Knauss Hall 
Michael Wilder & Yafinceio Harris, Peace During War Project 
Jennifer Machiorlatti, Professor of Communication, WMU 
Co-Sponsors: School of Communication 
"Divorce (Professional)" 
4:00 p.m. Wednesday, February 24th , & Thursday, 
February 25th, 6:00 p.m. 
Center for the Humanities, 2500 Knauss Hall 
Written by Kathy Purnell, Research Contracts Administrator, Office 
of the Vice President for Research, WMU 
Directed by Laura Henderson , Founder and Executive Producer, 
Queer Theater Kalamazoo · 
Co-Sponsors: Graduate College, Office of the Vice President for 
Research, Department of Political Science 
"Student Leadership in Academic Integrity" 
4:00p.m. Tuesday, March 22'd 
Brown & Gold Room, Bernhard Center 
Ceceilia Parnther, doctoral candidate, Department of Educationa l 
Leadership, Research, and Technology, WMU 
Co-Sponsors: Visit our website: https: //wm ich.edu/ethics 
"The Biopolitical Fragmentation of Life: Lessons Still to Learn a 
Decade after Schiavo" 
7:00p.m. Tuesday, April 12th 
Brown & Gold Room, Bernhard Center 
Tyler Gibb, Assistant Professor, Program in Medical Ethics, 
Humanities & Law, WM U Homer Stryker M.D. School of Medicine 
Co-Sponsor: WMU Homer St ryker M.D. School of Medicine 
Stay Informed About Ethics Center Events 
To be on the mailing list for the WMU Center for the Study of 
Ethics in Society, send us the following information: 
Event Update Preference (Check one): 
_E-Mail Only _Paper Mail Only _Both Paper and E-mail 
Send to : Center for the Study of Ethics in SocietY 
Western Michigan University 
1903 West Michigan Ave. 
Kalamazoo, MI 49008-5328 
Or: ethicscenter@wmich.edu 
You can also find the Center on Facebook and Twitter. 
The Center regularly pub! ishes papers presented as part of its lecture 
series. All papers are archived on Scholar Works, accessible via the 
Center' s website at http://www.wmich.edu/ethics/publications 
Lithograph on Front Cover: The Oaklands, WMU 

